Trademark: 97130395
Status Date
Wednesday, March 6, 2024
Filing Date
Wednesday, November 17, 2021
Published for Opposition
Tuesday, March 28, 2023
5 pharmaceutical preparations for diagnosis; diagnostic agents for pharmaceutical use; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; monoclonal antibodies for medical purposes; polyclonal antibodies for medical purposes; compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; chemical preparations for pharmaceutical purposes for the treatment of cancer or autoimmune diseases; immunoassay reagents for medical use; biological preparations for medical purposes for the treatment of cancer or autoimmune diseases; chemico-pharmaceutical preparations for the treatment of cancer or autoimmune diseases; preparations of microorganisms for medical purposes; pharmaceuticals for the treatment of cancer or autoimmune diseases; pharmaceutical compositions for the treatment of cancer or autoimmune diseases
42 pharmaceutical drug development services; research on the subject of pharmaceuticals; pharmaceutical drug development services; medicine research; analysis and evaluation of medical product development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on medical research being testing, inspection, and research of medical products; evaluating of clinical trial progress; development of biologics; research of biologics; biological research and analysis; drug discovery services; conducting clinical trials for others; scientific research; clinical trials; biological laboratory services; laboratory research in the field of chemistry; laboratory analysis in the field of chemistry; research and development of new products for others; pharmaceutical research and development
Mar 7, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 6, 2024
Sou Extension 1 Granted
Mar 6, 2024
Sou Extension 1 Filed
Mar 6, 2024
Sou Teas Extension Received
Sep 19, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 6, 2023
Extension Of Time To Oppose Process - Terminated
Apr 26, 2023
Extension Of Time To Oppose Received
Mar 28, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 28, 2023
Published For Opposition
Mar 8, 2023
Notification Of Notice Of Publication E-Mailed
Jan 31, 2023
Withdrawn From Pub - Og Review Query
Jan 17, 2023
Approved For Pub - Principal Register
Jan 12, 2023
Teas/Email Correspondence Entered
Jan 12, 2023
Correspondence Received In Law Office
Jan 12, 2023
Teas Response To Office Action Received
Aug 29, 2022
Notification Of Non-Final Action E-Mailed
Aug 29, 2022
Non-Final Action E-Mailed
Aug 29, 2022
Non-Final Action Written
Aug 29, 2022
Assigned To Examiner
Nov 23, 2021
New Application Office Supplied Data Entered
Nov 20, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
